BlombaeckM., EdsmirF., KoekumC., PaulC.: Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6 cis-diphenylhexametylcyclotetrasiloxane or estramustine-17-phosphate. Urol. Res., 6; 95 (1978).
2.
BüillerH. R., BoonT. A., HennyC. P., DabhoiwalaN. F., Ten CateJ. W.: Estrogen-induced deficiency and decrease in antitrombin III activity in patients with prostatic cancer. J. Urol., 128; 72 (1982).
3.
ChohanI. S., VermylenJ., SinghII: Sodium acetate buffer. A diluent of choice in the lysis time technique. Tromb. Diath. Haemorrh., 33; 226 (1975).
4.
ClaytonJ. K., AndersonJ. A., McNicolG. P.: Preoperative prediction of postoperative deep vein thrombosis. Brit. Med. J., 2; 910 (1976).
5.
ConardJ., HorellouM. H., CazenaveB., SamanaM., ZornJ. R., NeauC.: Antitrombin III in contraceptive treatments with oestroprogestagens or progestagen-only pills. Thromb. Haemostas., 42; 376 (1979).
6.
CostantiniA., DoniA., RizzoM., PaneraiA., GrechiG., BartolettiL.: Manifestazioni tromboemorragiche di interesse urologico. Atti Soc. It. Urol., 1; 1 (1971).
7.
DobbsR. M., BarberJ. A., WeigelJ. W., BerginJ. E.: Clotting predisposition in carcinoma of the prostate. J. Urol., 123; 706 (1980).
8.
LoweG. D. O., McArdleB. M., CarterD. C., McLarenD., OsborneD. H., SmithA., ForbesC. D., PrenticeC. R. M.: Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet, 2; 409 (1982).
9.
PetersonR. A., KrullP. E., FinleyP., EttingerM. G.: Changes in antitrombin III and plasminogen induced by oral contraceptives. Amer. J. Clin. Pathol., 53; 468 (1970).
10.
PollerL.: Oral contraception, blood coagulation and platelets. In: Recent Advanced in Blood Coagulation.PollerL. ed., p. 181. Churchill Livingstone, London1973.
11.
StadelB. V., SternthalP. M., SchlesselmanJ.: Variation of ethinylestradiol blood levels among healthy women using oral contraceptives. Fertil. & Steril., 33; 257 (1980).
12.
StagniG., CalestaniF., TronciA., PolettiF., PotíR., ManottiC., BezziE.: Adenocarcinoma della prostata (stadio C e D) ed emocoagulazione. Comunicaz. XXXI Convegno Soc. Urologi Nord Italia, S. Margherita Ligure 1982. Urologia, 50; 24 (1983).
13.
VarenhorstE., RisbergB.: Effects of estrogen, orchidectomy and ciproterone acetate on tissue fibrinolysis in patients with carcinoma of the prostate. Invest. Urol., 18; 355 (1981).
14.
VarenhorstE., WallentinL., RisbergB.: The effects of orchiectomy, oestrogens and ciproterone acetate on the antitrombin III concentration in carcinoma of the prostate. Urol. Res., 9; 25 (1981).
15.
WuK. K., HoakJ. C.: A new method for the quantitative detection of platelet aggregates in patient with arterial insufficiency. Lancet, 2; 924 (1974).
16.
ZuckT. F., BerginJ. J., RaymondJ. M., DwyreW. R.: Implication of depressed Antitrombin III activity associated with oral contraceptives. Surg., Gynec. & Obst., 133; 609 (1971).